25 XP   0   0   10

Cochlear Ltd
Buy, Hold or Sell?

Let's analyse Cochlear together

PenkeI guess you are interested in Cochlear Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cochlear Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Cochlear Ltd

I send you an email if I find something interesting about Cochlear Ltd.

Quick analysis of Cochlear (30 sec.)










What can you expect buying and holding a share of Cochlear? (30 sec.)

How much money do you get?

How much money do you get?
A$7.73
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
A$26.54
Expected worth in 1 year
A$30.17
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
A$15.62
Return On Investment
4.8%

For what price can you sell your share?

Current Price per Share
A$322.90
Expected price per share
A$271.16 - A$348.05
How sure are you?
50%

1. Valuation of Cochlear (5 min.)




Live pricePrice per Share (EOD)

A$322.90

Intrinsic Value Per Share

A$21.07 - A$159.27

Total Value Per Share

A$47.61 - A$185.81

2. Growth of Cochlear (5 min.)




Is Cochlear growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1b$1b$40.7m3.6%

How much money is Cochlear making?

Current yearPrevious yearGrowGrow %
Making money$193.9m$186.5m$7.4m3.8%
Net Profit Margin15.4%17.6%--

How much money comes from the company's main activities?

3. Financial Health of Cochlear (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#34 / 334

Most Revenue
#16 / 334

Most Profit
#16 / 334

What can you expect buying and holding a share of Cochlear? (5 min.)

Welcome investor! Cochlear's management wants to use your money to grow the business. In return you get a share of Cochlear.

What can you expect buying and holding a share of Cochlear?

First you should know what it really means to hold a share of Cochlear. And how you can make/lose money.

Speculation

The Price per Share of Cochlear is A$322.90. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cochlear.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cochlear, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$26.54. Based on the TTM, the Book Value Change Per Share is A$0.91 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$3.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cochlear.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps2.940.9%2.940.9%2.840.9%1.870.6%1.820.6%
Usd Book Value Change Per Share0.590.2%0.590.2%-0.050.0%2.220.7%1.360.4%
Usd Dividend Per Share1.930.6%1.930.6%1.900.6%1.660.5%1.510.5%
Usd Total Gains Per Share2.520.8%2.520.8%1.860.6%3.881.2%2.870.9%
Usd Price Per Share147.80-147.80-128.20-138.75-109.29-
Price to Earnings Ratio50.22-50.22-45.20-28.62-36.31-
Price-to-Total Gains Ratio58.67-58.67-69.09-46.75-44.06-
Price to Book Ratio8.63-8.63-7.75-10.73-13.86-
Price-to-Total Gains Ratio58.67-58.67-69.09-46.75-44.06-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share208.33508
Number of shares4
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share1.931.66
Usd Book Value Change Per Share0.592.22
Usd Total Gains Per Share2.523.88
Gains per Quarter (4 shares)10.0815.51
Gains per Year (4 shares)40.3062.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
131930263652
26219705371114
3932811079107176
412438150106142238
515547190132178300
618656230159213362
721666270185249424
824775310212284486
927884350238320548
1030994390265355610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%27.01.00.096.4%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%24.04.00.085.7%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%28.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%28.00.00.0100.0%

Fundamentals of Cochlear

About Cochlear Ltd

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-04-10 01:51:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Cochlear Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cochlear earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cochlear to the Medical Devices industry mean.
  • A Net Profit Margin of 15.4% means that $0.15 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cochlear Ltd:

  • The MRQ is 15.4%. The company is making a huge profit. +2
  • The TTM is 15.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ15.4%TTM15.4%0.0%
TTM15.4%YOY17.6%-2.2%
TTM15.4%5Y11.3%+4.0%
5Y11.3%10Y13.7%-2.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ15.4%-12.4%+27.8%
TTM15.4%-20.4%+35.8%
YOY17.6%-14.8%+32.4%
5Y11.3%-21.3%+32.6%
10Y13.7%-25.0%+38.7%
1.1.2. Return on Assets

Shows how efficient Cochlear is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cochlear to the Medical Devices industry mean.
  • 11.7% Return on Assets means that Cochlear generated $0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cochlear Ltd:

  • The MRQ is 11.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 11.7%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ11.7%TTM11.7%0.0%
TTM11.7%YOY11.7%0.0%
TTM11.7%5Y9.5%+2.2%
5Y9.5%10Y13.7%-4.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ11.7%-4.1%+15.8%
TTM11.7%-4.7%+16.4%
YOY11.7%-4.8%+16.5%
5Y9.5%-4.0%+13.5%
10Y13.7%-5.2%+18.9%
1.1.3. Return on Equity

Shows how efficient Cochlear is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cochlear to the Medical Devices industry mean.
  • 17.2% Return on Equity means Cochlear generated $0.17 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cochlear Ltd:

  • The MRQ is 17.2%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 17.2%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.2%TTM17.2%0.0%
TTM17.2%YOY17.2%+0.0%
TTM17.2%5Y15.0%+2.2%
5Y15.0%10Y26.8%-11.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ17.2%-4.2%+21.4%
TTM17.2%-5.8%+23.0%
YOY17.2%-5.7%+22.9%
5Y15.0%-6.3%+21.3%
10Y26.8%-7.1%+33.9%

1.2. Operating Efficiency of Cochlear Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cochlear is operating .

  • Measures how much profit Cochlear makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cochlear to the Medical Devices industry mean.
  • An Operating Margin of 21.1% means the company generated $0.21  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cochlear Ltd:

  • The MRQ is 21.1%. The company is operating efficient. +1
  • The TTM is 21.1%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ21.1%TTM21.1%0.0%
TTM21.1%YOY22.0%-1.0%
TTM21.1%5Y22.0%-1.0%
5Y22.0%10Y22.2%-0.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ21.1%-24.3%+45.4%
TTM21.1%-16.4%+37.5%
YOY22.0%-13.7%+35.7%
5Y22.0%-19.9%+41.9%
10Y22.2%-24.5%+46.7%
1.2.2. Operating Ratio

Measures how efficient Cochlear is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.79 means that the operating costs are $0.79 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cochlear Ltd:

  • The MRQ is 0.789. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.789. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.789TTM0.7890.000
TTM0.789YOY0.780+0.010
TTM0.7895Y0.788+0.001
5Y0.78810Y0.799-0.011
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7891.442-0.653
TTM0.7891.439-0.650
YOY0.7801.431-0.651
5Y0.7881.436-0.648
10Y0.7991.374-0.575

1.3. Liquidity of Cochlear Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cochlear is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.36 means the company has $2.36 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cochlear Ltd:

  • The MRQ is 2.356. The company is able to pay all its short-term debts. +1
  • The TTM is 2.356. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.356TTM2.3560.000
TTM2.356YOY2.515-0.160
TTM2.3565Y2.300+0.055
5Y2.30010Y2.108+0.192
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3562.726-0.370
TTM2.3562.732-0.376
YOY2.5153.510-0.995
5Y2.3003.617-1.317
10Y2.1083.499-1.391
1.3.2. Quick Ratio

Measures if Cochlear is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cochlear to the Medical Devices industry mean.
  • A Quick Ratio of 1.91 means the company can pay off $1.91 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cochlear Ltd:

  • The MRQ is 1.910. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.910. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.910TTM1.9100.000
TTM1.910YOY2.063-0.153
TTM1.9105Y2.109-0.199
5Y2.10910Y1.700+0.409
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9101.491+0.419
TTM1.9101.633+0.277
YOY2.0632.113-0.050
5Y2.1092.295-0.186
10Y1.7002.255-0.555

1.4. Solvency of Cochlear Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cochlear assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cochlear to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.32 means that Cochlear assets are financed with 31.9% credit (debt) and the remaining percentage (100% - 31.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cochlear Ltd:

  • The MRQ is 0.319. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.319. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.319TTM0.3190.000
TTM0.319YOY0.316+0.003
TTM0.3195Y0.374-0.055
5Y0.37410Y0.457-0.083
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3190.389-0.070
TTM0.3190.386-0.067
YOY0.3160.335-0.019
5Y0.3740.442-0.068
10Y0.4570.461-0.004
1.4.2. Debt to Equity Ratio

Measures if Cochlear is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cochlear to the Medical Devices industry mean.
  • A Debt to Equity ratio of 46.9% means that company has $0.47 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cochlear Ltd:

  • The MRQ is 0.469. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.469. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.469TTM0.4690.000
TTM0.469YOY0.462+0.006
TTM0.4695Y0.622-0.153
5Y0.62210Y0.907-0.285
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4690.551-0.082
TTM0.4690.554-0.085
YOY0.4620.479-0.017
5Y0.6220.622+0.000
10Y0.9070.674+0.233

2. Market Valuation of Cochlear Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cochlear generates.

  • Above 15 is considered overpriced but always compare Cochlear to the Medical Devices industry mean.
  • A PE ratio of 50.22 means the investor is paying $50.22 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cochlear Ltd:

  • The EOD is 70.785. Based on the earnings, the company is expensive. -2
  • The MRQ is 50.216. Based on the earnings, the company is expensive. -2
  • The TTM is 50.216. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD70.785MRQ50.216+20.569
MRQ50.216TTM50.2160.000
TTM50.216YOY45.205+5.012
TTM50.2165Y28.625+21.592
5Y28.62510Y36.314-7.690
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD70.785-1.077+71.862
MRQ50.216-1.704+51.920
TTM50.216-2.081+52.297
YOY45.205-2.978+48.183
5Y28.625-2.379+31.004
10Y36.314-1.726+38.040
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cochlear Ltd:

  • The EOD is 79.843. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 56.642. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 56.642. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD79.843MRQ56.642+23.201
MRQ56.642TTM56.6420.000
TTM56.642YOY43.664+12.978
TTM56.6425Y43.065+13.577
5Y43.06510Y46.708-3.643
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD79.843-0.932+80.775
MRQ56.642-1.578+58.220
TTM56.642-2.973+59.615
YOY43.664-6.318+49.982
5Y43.065-5.307+48.372
10Y46.708-5.171+51.879
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cochlear is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 8.63 means the investor is paying $8.63 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cochlear Ltd:

  • The EOD is 12.167. Based on the equity, the company is expensive. -2
  • The MRQ is 8.632. Based on the equity, the company is overpriced. -1
  • The TTM is 8.632. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD12.167MRQ8.632+3.536
MRQ8.632TTM8.6320.000
TTM8.632YOY7.753+0.879
TTM8.6325Y10.733-2.102
5Y10.73310Y13.861-3.127
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD12.1671.876+10.291
MRQ8.6322.372+6.260
TTM8.6322.434+6.198
YOY7.7533.217+4.536
5Y10.7333.893+6.840
10Y13.8614.245+9.616
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cochlear Ltd.

3.1. Funds holding Cochlear Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2020-10-31Vanguard International Stock Index-Total Intl Stock Indx1.47-968855--
2021-01-31Invesco Oppenheimer International Small-Mid Company Fund1.0199999-667730--
2021-01-31Franklin Global Tr-Franklin International Growth Fund0.82-540000--
2020-11-30BNY Mellon International Stock Fd0.66000004-431100--
2020-12-31Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund0.62-409095--
2021-02-28Aberdeen Standard SICAV I-Asia Equity Fund0.57-376610--
2020-12-31Bridge Builder Tr-Bridge Builder International Equity Fd0.47999998-314245--
2021-01-31Price (T.Rowe) International Discovery Fund0.47-309145--
2021-02-28iShares Core MSCI EAFE ETF0.45-294304--
2020-12-31Baillie Gifford International Alpha Fund0.34-221431--
Total 6.899999920453251500.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Cochlear Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.9080.9080%-0.073+108%3.442-74%2.109-57%
Book Value Per Share--26.53826.5380%25.630+4%22.071+20%14.528+83%
Current Ratio--2.3562.3560%2.515-6%2.300+2%2.108+12%
Debt To Asset Ratio--0.3190.3190%0.316+1%0.374-15%0.457-30%
Debt To Equity Ratio--0.4690.4690%0.462+1%0.622-25%0.907-48%
Dividend Per Share--2.9962.9960%2.950+2%2.566+17%2.342+28%
Eps--4.5624.5620%4.396+4%2.902+57%2.822+62%
Free Cash Flow Per Share--4.0444.0440%4.551-11%1.997+103%2.210+83%
Free Cash Flow To Equity Per Share---0.666-0.6660%1.195-156%1.973-134%1.131-159%
Gross Profit Margin---1.018-1.0180%-0.725-29%0.048-2221%-0.399-61%
Intrinsic Value_10Y_max--159.272--------
Intrinsic Value_10Y_min--21.073--------
Intrinsic Value_1Y_max--6.493--------
Intrinsic Value_1Y_min--2.047--------
Intrinsic Value_3Y_max--26.724--------
Intrinsic Value_3Y_min--6.242--------
Intrinsic Value_5Y_max--55.654--------
Intrinsic Value_5Y_min--10.507--------
Market Cap21148044890.000+29%15094991887.64015094991887.6400%13068627360.200+16%14125516211.196+7%11115009060.798+36%
Net Profit Margin--0.1540.1540%0.176-13%0.113+36%0.137+13%
Operating Margin--0.2110.2110%0.220-4%0.220-4%0.222-5%
Operating Ratio--0.7890.7890%0.780+1%0.788+0%0.799-1%
Pb Ratio12.167+29%8.6328.6320%7.753+11%10.733-20%13.861-38%
Pe Ratio70.785+29%50.21650.2160%45.205+11%28.625+75%36.314+38%
Price Per Share322.900+29%229.070229.0700%198.700+15%215.042+7%169.393+35%
Price To Free Cash Flow Ratio79.843+29%56.64256.6420%43.664+30%43.065+32%46.708+21%
Price To Total Gains Ratio82.709+29%58.67558.6750%69.085-15%46.752+26%44.057+33%
Quick Ratio--1.9101.9100%2.063-7%2.109-9%1.700+12%
Return On Assets--0.1170.1170%0.1170%0.095+23%0.137-15%
Return On Equity--0.1720.1720%0.172+0%0.150+15%0.268-36%
Total Gains Per Share--3.9043.9040%2.876+36%6.008-35%4.451-12%
Usd Book Value--1128325760.0001128325760.0000%1087613640.000+4%935733560.000+21%615462409.400+83%
Usd Book Value Change Per Share--0.5860.5860%-0.047+108%2.221-74%1.361-57%
Usd Book Value Per Share--17.12317.1230%16.536+4%14.240+20%9.374+83%
Usd Dividend Per Share--1.9331.9330%1.903+2%1.655+17%1.511+28%
Usd Eps--2.9432.9430%2.836+4%1.872+57%1.821+62%
Usd Free Cash Flow--171945800.000171945800.0000%193108360.000-11%84856703.871+103%93635166.095+84%
Usd Free Cash Flow Per Share--2.6092.6090%2.936-11%1.289+103%1.426+83%
Usd Free Cash Flow To Equity Per Share---0.430-0.4300%0.771-156%1.273-134%0.730-159%
Usd Market Cap13644718563.028+29%9739288765.9059739288765.9050%8431878372.801+16%9113783059.464+7%7171403846.027+36%
Usd Price Per Share208.335+29%147.796147.7960%128.201+15%138.745+7%109.292+35%
Usd Profit--193947120.000193947120.0000%186527320.000+4%123181584.000+57%119522396.720+62%
Usd Revenue--1261817640.0001261817640.0000%1058837720.000+19%1015428664.000+24%861197217.120+47%
Usd Total Gains Per Share--2.5192.5190%1.856+36%3.877-35%2.872-12%
 EOD+4 -4MRQTTM+0 -0YOY+17 -195Y+23 -1310Y+23 -13

4.2. Fundamental Score

Let's check the fundamental score of Cochlear Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1570.785
Price to Book Ratio (EOD)Between0-112.167
Net Profit Margin (MRQ)Greater than00.154
Operating Margin (MRQ)Greater than00.211
Quick Ratio (MRQ)Greater than11.910
Current Ratio (MRQ)Greater than12.356
Debt to Asset Ratio (MRQ)Less than10.319
Debt to Equity Ratio (MRQ)Less than10.469
Return on Equity (MRQ)Greater than0.150.172
Return on Assets (MRQ)Greater than0.050.117
Total8/10 (80.0%)

4.3. Technical Score

Let's check the technical score of Cochlear Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.612
Ma 20Greater thanMa 50325.487
Ma 50Greater thanMa 100331.331
Ma 100Greater thanMa 200312.598
OpenGreater thanClose323.790
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Net Interest Income  -4,500-6,000-10,5002,100-8,4002,200-6,20013,3007,100



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets2,568,700
Total Liabilities819,900
Total Stockholder Equity1,748,800
 As reported
Total Liabilities 819,900
Total Stockholder Equity+ 1,748,800
Total Assets = 2,568,700

Assets

Total Assets2,568,700
Total Current Assets1,361,500
Long-term Assets1,207,200
Total Current Assets
Cash And Cash Equivalents 555,500
Short-term Investments 90,800
Net Receivables 457,500
Inventory 311,500
Total Current Assets  (as reported)1,361,500
Total Current Assets  (calculated)1,415,300
+/- 53,800
Long-term Assets
Property Plant Equipment 447,200
Goodwill 256,100
Long Term Investments 97,300
Intangible Assets 444,100
Other Assets 0
Long-term Assets  (as reported)1,207,200
Long-term Assets  (calculated)1,244,700
+/- 37,500

Liabilities & Shareholders' Equity

Total Current Liabilities578,000
Long-term Liabilities241,900
Total Stockholder Equity1,748,800
Total Current Liabilities
Short-term Debt 39,200
Accounts payable 270,400
Other Current Liabilities 206,800
Total Current Liabilities  (as reported)578,000
Total Current Liabilities  (calculated)516,400
+/- 61,600
Long-term Liabilities
Long term Debt Total 162,600
Other Liabilities 79,300
Long-term Liabilities  (as reported)241,900
Long-term Liabilities  (calculated)241,900
+/- 0
Total Stockholder Equity
Common Stock1,250,300
Retained Earnings 555,400
Accumulated Other Comprehensive Income -56,900
Other Stockholders Equity 0
Total Stockholder Equity (as reported)1,748,800
Total Stockholder Equity (calculated)1,748,800
+/-0
Other
Capital Stock1,250,300
Cash And Equivalents555,500
Cash and Short Term Investments 555,500
Common Stock Shares Outstanding 65,897
Current Deferred Revenue61,600
Liabilities and Stockholders Equity 2,568,700
Net Debt -353,700
Net Invested Capital 1,748,800
Net Tangible Assets 1,304,700
Net Working Capital 783,500
Property Plant and Equipment Gross 710,600
Short Long Term Debt Total 201,800



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-301997-06-301996-06-30
> Total Assets 
48,242
51,287
69,113
82,939
93,771
129,048
160,428
230,579
264,539
505,747
545,924
585,737
607,916
679,373
751,719
741,047
702,542
764,501
789,036
869,056
957,363
1,136,359
1,156,900
1,379,200
2,583,100
2,426,100
2,465,100
2,568,700
2,568,7002,465,1002,426,1002,583,1001,379,2001,156,9001,136,359957,363869,056789,036764,501702,542741,047751,719679,373607,916585,737545,924505,747264,539230,579160,428129,04893,77182,93969,11351,28748,242
   > Total Current Assets 
35,223
38,191
52,566
64,011
71,971
106,438
123,179
179,482
200,402
251,030
279,203
323,738
322,096
371,319
447,888
429,884
373,881
405,222
420,879
489,026
543,028
585,960
584,200
635,000
1,477,500
1,230,000
1,327,000
1,361,500
1,361,5001,327,0001,230,0001,477,500635,000584,200585,960543,028489,026420,879405,222373,881429,884447,888371,319322,096323,738279,203251,030200,402179,482123,179106,43871,97164,01152,56638,19135,223
       Cash And Cash Equivalents 
16,079
12,958
19,227
33,831
23,201
31,025
10,539
43,891
75,946
106,077
87,073
83,382
36,687
80,016
42,808
72,423
68,486
52,689
56,127
72,208
75,417
89,540
61,500
78,600
565,000
609,600
629,300
555,500
555,500629,300609,600565,00078,60061,50089,54075,41772,20856,12752,68968,48672,42342,80880,01636,68783,38287,073106,07775,94643,89110,53931,02523,20133,83119,22712,95816,079
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
204
0
0
0
0
3,853
11,454
18,430
0
365,000
365,000
27,300
68,800
90,800
90,80068,80027,300365,000365,000018,43011,4543,853000020400000000000000
       Net Receivables 
11,394
15,357
18,248
17,013
31,789
42,511
69,284
78,578
66,656
82,961
109,388
143,076
173,266
173,256
210,690
238,276
189,085
203,748
214,953
249,744
281,925
292,139
316,700
319,700
304,900
365,500
390,400
457,500
457,500390,400365,500304,900319,700316,700292,139281,925249,744214,953203,748189,085238,276210,690173,256173,266143,076109,38882,96166,65678,57869,28442,51131,78917,01318,24815,35711,394
       Inventory 
5,800
8,089
13,628
11,361
14,068
27,068
36,380
45,023
44,837
49,120
76,822
91,890
99,169
105,944
104,407
106,126
101,298
131,574
128,613
145,861
154,103
160,011
167,400
195,400
223,800
216,100
270,200
311,500
311,500270,200216,100223,800195,400167,400160,011154,103145,861128,613131,574101,298106,126104,407105,94499,16991,89076,82249,12044,83745,02336,38027,06814,06811,36113,6288,0895,800
       Other Current Assets 
1,950
1,787
1,463
1,806
2,913
5,834
6,976
11,990
12,963
12,872
5,920
5,390
12,974
12,103
89,983
13,059
15,012
17,211
21,186
17,360
20,129
25,840
38,600
41,300
18,800
38,800
37,100
37,000
37,00037,10038,80018,80041,30038,60025,84020,12917,36021,18617,21115,01213,05989,98312,10312,9745,3905,92012,87212,96311,9906,9765,8342,9131,8061,4631,7871,950
   > Long-term Assets 
13,019
13,096
16,547
18,928
21,800
22,610
37,249
51,097
64,137
254,717
266,721
261,999
285,820
308,054
303,831
311,163
328,661
359,279
368,157
380,030
414,335
550,399
572,700
744,200
1,105,600
1,196,100
1,138,100
1,207,200
1,207,2001,138,1001,196,1001,105,600744,200572,700550,399414,335380,030368,157359,279328,661311,163303,831308,054285,820261,999266,721254,71764,13751,09737,24922,61021,80018,92816,54713,09613,019
       Property Plant Equipment 
6,204
6,291
6,744
7,222
10,311
12,541
24,925
27,336
29,523
28,589
34,873
40,565
43,420
46,810
49,597
69,357
59,611
65,898
75,776
80,809
86,878
120,107
128,400
166,500
438,800
428,500
439,200
447,200
447,200439,200428,500438,800166,500128,400120,10786,87880,80975,77665,89859,61169,35749,59746,81043,42040,56534,87328,58929,52327,33624,92512,54110,3117,2226,7446,2916,204
       Goodwill 
0
0
0
0
0
0
0
0
0
176,739
185,352
1,416
187,741
173,599
159,877
159,137
151,066
170,959
170,259
170,503
171,356
267,104
263,600
268,800
270,900
267,300
257,100
256,100
256,100257,100267,300270,900268,800263,600267,104171,356170,503170,259170,959151,066159,137159,877173,599187,7411,416185,352176,739000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,755
15,064
15,800
47,800
94,900
199,500
119,100
97,300
97,300119,100199,50094,90047,80015,80015,06413,75500000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
7,190
15,025
15,846
194,852
21,017
34,660
51,962
49,413
55,649
64,815
63,856
58,028
52,982
72,872
81,700
155,600
410,300
385,500
392,500
444,100
444,100392,500385,500410,300155,60081,70072,87252,98258,02863,85664,81555,64949,41351,96234,66021,017194,85215,84615,0257,19000000000
       Long-term Assets Other 
267
326
324
344
463
251
215
9,796
9,633
10,460
0
6,178
15,963
31,086
25,143
17,184
11,840
944
5,505
63
12,220
8,666
2,500
5,400
-270,900
-267,300
-257,100
-256,100
-256,100-257,100-267,300-270,9005,4002,5008,66612,220635,50594411,84017,18425,14331,08615,9636,178010,4609,6339,796215251463344324326267
> Total Liabilities 
29,786
27,980
37,018
48,889
50,942
73,553
85,012
110,892
119,010
339,877
336,146
324,928
288,575
315,139
313,411
237,764
317,662
407,588
459,831
513,670
508,806
592,712
546,100
653,300
1,181,600
736,500
779,400
819,900
819,900779,400736,5001,181,600653,300546,100592,712508,806513,670459,831407,588317,662237,764313,411315,139288,575324,928336,146339,877119,010110,89285,01273,55350,94248,88937,01827,98029,786
   > Total Current Liabilities 
29,411
27,615
36,609
48,398
50,393
72,938
83,372
99,440
106,296
186,949
203,456
279,548
124,945
117,143
213,148
223,460
261,943
191,830
169,578
403,284
251,100
346,615
287,700
359,500
817,500
402,500
527,600
578,000
578,000527,600402,500817,500359,500287,700346,615251,100403,284169,578191,830261,943223,460213,148117,143124,945279,548203,456186,949106,29699,44083,37272,93850,39348,39836,60927,61529,411
       Short-term Debt 
0
0
0
0
0
0
0
15,005
25,867
64,206
70,547
161,337
15,438
0
73,811
60,000
45,744
3,309
3,141
168,159
3,978
84,687
3,700
3,300
419,100
31,900
78,700
39,200
39,20078,70031,900419,1003,3003,70084,6873,978168,1593,1413,30945,74460,00073,811015,438161,33770,54764,20625,86715,0050000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
237,415
212,711
3,978
84,687
3,700
3,300
393,100
0
42,600
0
042,6000393,1003,3003,70084,6873,978212,711237,415000000000000000000
       Accounts payable 
0
0
0
0
21,879
30,511
21,136
29,340
31,657
46,539
57,345
61,923
60,830
64,881
70,763
85,047
100,218
80,632
78,644
99,858
110,354
130,900
140,500
160,800
159,300
202,900
232,400
270,400
270,400232,400202,900159,300160,800140,500130,900110,35499,85878,64480,632100,21885,04770,76364,88160,83061,92357,34546,53931,65729,34021,13630,51121,8790000
       Other Current Liabilities 
17,488
15,486
21,776
30,563
28,514
42,427
62,236
55,095
39,797
55,422
52,039
38,950
34,319
37,584
49,526
59,681
97,892
85,383
72,642
114,682
105,504
105,771
117,000
152,500
192,100
124,900
161,800
206,800
206,800161,800124,900192,100152,500117,000105,771105,504114,68272,64285,38397,89259,68149,52637,58434,31938,95052,03955,42239,79755,09562,23642,42728,51430,56321,77615,48617,488
   > Long-term Liabilities 
375
365
409
491
549
615
1,640
11,452
12,714
152,928
132,690
45,380
163,630
197,996
100,263
14,304
55,719
215,758
290,253
110,386
257,706
246,097
258,400
293,800
364,100
334,000
251,800
241,900
241,900251,800334,000364,100293,800258,400246,097257,706110,386290,253215,75855,71914,304100,263197,996163,63045,380132,690152,92812,71411,4521,640615549491409365375
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
189,260
134,235
144,000
178,300
285,400
232,400
175,200
162,600
162,600175,200232,400285,400178,300144,000134,235189,26000000000000000000000
       Other Liabilities 
0
0
0
0
549
615
1,640
11,452
12,714
13,642
7,197
7,828
8,633
9,234
17,329
11,264
35,791
48,598
55,979
65,834
68,446
111,900
114,400
115,500
71,300
101,600
76,600
79,300
79,30076,600101,60071,300115,500114,400111,90068,44665,83455,97948,59835,79111,26417,3299,2348,6337,8287,19713,64212,71411,4521,6406155490000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,900
50,400
58,100
53,300
33,000
0
033,00053,30058,10050,40032,9000000000000000000000000
> Total Stockholder Equity
18,456
23,307
32,095
34,050
42,829
55,495
75,416
119,687
139,018
161,129
207,537
260,809
319,341
364,234
438,308
503,283
384,880
356,913
329,205
355,386
448,557
543,647
610,800
725,900
1,401,500
1,689,600
1,685,700
1,748,800
1,748,8001,685,7001,689,6001,401,500725,900610,800543,647448,557355,386329,205356,913384,880503,283438,308364,234319,341260,809207,537161,129139,018119,68775,41655,49542,82934,05032,09523,30718,456
   Common Stock
5,000
5,000
5,000
6,383
7,964
10,883
14,959
23,089
50,746
50,746
66,663
69,998
82,972
97,435
119,842
123,226
125,865
128,196
144,136
144,136
158,940
169,367
173,000
182,300
1,272,400
1,276,600
1,276,600
1,250,300
1,250,3001,276,6001,276,6001,272,400182,300173,000169,367158,940144,136144,136128,196125,865123,226119,84297,43582,97269,99866,66350,74650,74623,08914,95910,8837,9646,3835,0005,0005,000
   Retained Earnings 
14,213
18,806
24,341
26,518
31,338
41,189
54,524
95,410
89,267
99,959
137,864
181,227
223,334
269,234
299,023
360,189
280,506
270,558
217,260
237,451
304,279
387,081
471,600
558,900
116,400
355,100
455,300
555,400
555,400455,300355,100116,400558,900471,600387,081304,279237,451217,260270,558280,506360,189299,023269,234223,334181,227137,86499,95989,26795,41054,52441,18931,33826,51824,34118,80614,213
   Accumulated Other Comprehensive Income 
-5,165
-6,650
-8,497
-10,066
-12,411
-15,831
-18,279
1,188
-995
10,424
3,010
9,584
13,035
-2,435
19,443
19,868
-21,491
-41,841
-32,191
-26,201
-14,662
-12,801
-33,800
-15,300
12,700
57,900
-46,200
-56,900
-56,900-46,20057,90012,700-15,300-33,800-12,801-14,662-26,201-32,191-41,841-21,49119,86819,443-2,43513,0359,5843,01010,424-9951,188-18,279-15,831-12,411-10,066-8,497-6,650-5,165
   Capital Surplus 0000000000000000000000000000
   Treasury Stock0000000-363-8,463-8,463-9,408-4,729-3,489-2,826-1,992-2,092-1,371-1,3710000000000
   Other Stockholders Equity 
4,408
6,151
11,251
11,215
15,938
19,254
24,212
0
0
0
0
0
0
0
0
0
0
0
0
0
-44,184
-12,900
-33,800
-15,300
-1,388,800
-1,631,700
0
0
00-1,631,700-1,388,800-15,300-33,800-12,900-44,184000000000000024,21219,25415,93811,21511,2516,1514,408



Balance Sheet

Currency in AUD. All numbers in thousands.